New 'Smart Bomb' drug enters human testing for Tough-to-Treat cancers
NCT ID NCT06466187
Summary
This is an early-stage study testing a new experimental drug called SGN-MesoC2 in people with advanced solid tumors that have come back or stopped responding to standard treatments. The main goal is to find a safe dose and see how the body handles the drug. The drug is designed to target and kill cancer cells specifically, and the study will also look for early signs that it might help shrink tumors.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Atrium Health Wake Forest Baptist
Winston-Salem, North Carolina, 27157, United States
-
McGill University Health Centre
Montreal, Quebec, H4A 3J1, Canada
-
SCRI Oncology Partners
Nashville, Tennessee, 37203, United States
-
START Mountain Region
West Valley City, Utah, 84119, United States
-
START Mountain Region, LLC
Salt Lake City, Utah, 84119, United States
-
START San Antonio, LLC
San Antonio, Texas, 78229, United States
-
Sarah Cannon Research Institute - Pharmacy
Nashville, Tennessee, 37203, United States
-
The Board of Trustees of the University of Alabama for the University of Alabama at Birmingham
Birmingham, Alabama, 35294, United States
-
The Research Institute of the McGill University Health Centre
Montreal, Quebec, H3H 2R9, Canada
-
The University of Alabama at Birmingham
Birmingham, Alabama, 35249, United States
-
The University of Kansas Cancer Center - Indian Creek Campus
Overland Park, Kansas, 66211, United States
-
The University of Kansas Cancer Center - Westwood
Westwood, Kansas, 66205, United States
-
The University of Kansas Cancer Center, Investigational Drug Services
Westwood, Kansas, 66205, United States
-
The University of Kansas Clinical Research Center
Fairway, Kansas, 66205, United States
-
The University of Kansas Hospital
Kansas City, Kansas, 66160, United States
-
The University of Kansas Hospital Cambridge North Tower A
Kansas City, Kansas, 66160, United States
-
The University of Kansas Medical Center Medical Office Building
Kansas City, Kansas, 66160, United States
-
University Health Network
Toronto, Ontario, M5G 2C4, Canada
-
University Health Network, Princess Margaret Cancer Centre
Toronto, Ontario, M5G 2M9, Canada
-
University of Alabama at Birmingham
Birmingham, Alabama, 35233, United States
-
University of Alabama at Birmingham
Birmingham, Alabama, 35249, United States
Conditions
Explore the condition pages connected to this study.